Topic: Infectious disease

Drug Engineered at UT to Treat Anthrax Gains FDA Approval

April 4, 2016
Colonies of the bacterium Bacillus anthracis, which causes anthrax

Researchers at UT Austin successfully culminated years of work when a drug they engineered for the treatment and prevention of inhalational anthrax, sold as Anthim, received approval from the FDA.

Read more

How Zika Could Spread Farther Than WHO Forecasts

March 22, 2016
Risk map for spread of Zika virus (U.S.)

More cities than previously assumed could soon grapple with the Zika virus if two species of mosquitos are found to be equally effective carriers of the disease.

Read more

Bacteria Suppress Their Antibiotic-Resistant Cousins

May 13, 2015
Pseudomonas aeruginosa

Doctors battling antibiotic resistant superbugs are in desparate need of new treatment options. New research suggests that the infecting bacteria might be turned against themselves to weaken their defenses.

Read more

HIV Not As Infectious Soon After Transmission As Thought

March 17, 2015

People who recently have been infected with HIV may not be as highly infectious as previously believed, a finding that could improve global efforts to prevent HIV transmission and save lives.

Read more

Researchers Discover Possible New Target to Attack Flu Virus

April 9, 2014

[caption id="attachment_45357" align="alignright" width="300" caption="This region of the NS1 viral protein binds the host protein DDX21, making it a potential target for new antivirals against the flu virus"]NS1 Protein[/caption]

AUSTIN, Texas  Scientists at The University of Texas at Austin have discovered that a protein produced by the influenza A virus helps it outwit one of our body's natural defense mechanisms. That makes the protein a potentially good target for antiviral drugs directed against the influenza A virus.

Read more